Their use in non-diabetics has risen by a staggering 700% in the US between 2019 and 2023.2 Despite its popularity, barriers exist high costs, limited supply, and lack of a structured multidisciplinary obesity programs make their use challenging for many patients
TB-500 : 43-amino-acid analog of thymosin 4, examined for actin binding/sequestration, cell motility, microtubule/cytoskeleton remodeling, and re-epithelialization in injury models
Aims to stimulate tissue regeneration, reduce inflammation, and modulate local healing environments
Comprehensive Wellness Approach We combine aesthetic results with overall health benefits
Pros: Affordable Established brand High dose per serving Cons: Tablet form less optimal Contains some binders 7
"HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections"